Which specific medications are causing this patient's Stevens-Johnson syndrome?

Identifying the Causative Medication in Stevens-Johnson Syndrome

The specific medication causing your patient's Stevens-Johnson syndrome must be identified through systematic drug history analysis, focusing on medications started 5-28 days before symptom onset, with particular attention to high-risk drugs including antibiotics (especially sulfonamides, penicillins, co-amoxiclav), anticonvulsants (lamotrigine, carbamazepine, phenytoin), allopurinol, NSAIDs, and other commonly implicated agents 1.

Systematic Approach to Drug Identification

Step 1: Obtain Comprehensive Drug History

You must document all medications taken in the previous 2 months, including 1:

• Prescription medications with exact start dates
• Over-the-counter medications
• Complementary/alternative therapies
• Any brand switches or medication errors
• Previous drug allergies and reaction types

Use multiple sources: patient, relatives, general practitioner, and pharmacist to ensure completeness 1.

Step 2: Create a Drug Timeline

Construct a timeline for each drug identifying 1:

• Date commenced and discontinued
• Latency period: The critical window is 5-28 days between drug initiation and SJS/TEN onset (unless previous exposure to the same drug, which may shorten latency)
• Pharmacokinetic parameters (half-life, renal/hepatic dysfunction affecting drug levels)
• Any drug interactions

Tools available: Web-based resources like www.drugrash.co.uk can facilitate timeline analysis 1.

Step 3: Assess Drug Notoriety

Prioritize drugs with known high association with SJS/TEN 1:

Most commonly implicated medications:

• Antibiotics: Sulfonamides (especially trimethoprim/sulfamethoxazole) 2, co-amoxiclav 3, 4, amoxicillin 5, penicillins 6, flucloxacillin 4
• Anticonvulsants: Lamotrigine, carbamazepine, phenytoin, sodium valproate 6
• Allopurinol 6, 4
• NSAIDs: Ibuprofen 6
• Other: Amitriptyline 6, lidocaine 4

Step 4: Evaluate Temporal Relationship

For each suspected drug, determine if it was present in the body at reaction onset by considering 1:

• Drug half-life and elimination time
• Patient's renal and hepatic function
• Potential drug interactions affecting metabolism

Step 5: Consider Alternative Causes

If no drug can be identified (occurs in approximately 15% of cases), consider 1:

• Mycoplasma infection
• Other infectious triggers

Critical Action: Immediate Drug Discontinuation

Discontinue any potential culprit drug immediately upon SJS/TEN suspicion 1. This is the single most important intervention affecting outcome.

Common Pitfalls to Avoid

1. Missing the temporal window: Don't exclude drugs started more than 28 days prior if they have long half-lives or if there's renal/hepatic impairment
2. Overlooking OTC medications: Patients often forget to mention non-prescription drugs
3. Ignoring previous exposures: A history of prior reaction to the same drug class significantly increases likelihood
4. Delaying discontinuation: Waiting for definitive identification before stopping suspected drugs worsens outcomes

Documentation Requirements

Once identified, the causative medication must be 1:

• Clearly documented in the patient's medical record
• Reported to pharmacovigilance authorities (MHRA in UK)
• Communicated to the patient with written information about drugs to avoid, including related medications that may cross-react
• Included in discharge letters to all healthcare providers

The patient must be educated that they should never receive this medication or drugs of the same class again 1.